ICLR Competitors & Alternatives
Compare ICON PLC with similar stocks in the same industry
Diagnostics & Research
ICLR
Main Stock$118.22
Tradestie Score
56
Market Cap
$14.96B
P/E Ratio
15.8
Revenue Growth
0.0%
Analyst Upside
+16.1%
Top Competitors
34 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 65 | Compare |
|
RVTY
Revvity, Inc.
|
$96.00
|
$10.65B | 46.3 | 57 | Compare |
|
QGEN
QIAGEN N.V.
|
$33.43
|
$10.04B | 17.0 | 58 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$155.38
|
$8.39B | - | 54 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$95.65
|
$7.81B | - | 60 | Compare |
|
RDNT
RadNet, Inc. Common Stock
|
$54.40
|
$6.00B | - | 56 | Compare |
|
BRKR
Bruker Corporation
|
$43.65
|
$5.27B | - | 62 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$15.67
|
$4.60B | 37.8 | 55 | Compare |
|
BLLN
BLLN
|
$86.62
|
$4.04B | 159.9 | 54 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$43.66
|
$3.26B | - | 54 | Compare |
More ICLR Analysis
Data updated: May 18, 2026 | Industry: Diagnostics & Research (SIC 8731)
34 stocks in this industry